AGIREST-L

Triple Relief for Faster Breathing & Cough Control

100ml
Pharma
Respiratory Care

Product highlights

  • Triple action formula for productive cough & bronchospasm
  • Helps clear mucus and eases breathing
  • Provides faster cough resolution
  • Improves airway flow and chest comfort
  • Paediatric-friendly cough management
AGIREST-L Syrup is a paediatric respiratory formulation designed to provide effective relief from productive cough, mucus congestion, and bronchospasm. Its triple combination helps loosen thick mucus, improve airway opening, and support comfortable breathing in children.
Dosage Form
Paediatric Syrup
Product Name
AGIREST-L Syrup
Composition
Levosalbutamol 1 mg + Ambroxol HCl 30 mg + Guaiphenesin 50 mg
Therapeutic Segment
Paediatric Respiratory Care / Productive Cough Management
Pharmacological Action
Bronchodilator + Mucolytic + Expectorant combination
Mechanism
Levosalbutamol opens airways, Ambroxol breaks thick mucus, and Guaiphenesin enhances mucus expulsion.
Key Clinical Benefits
  • Relieves productive cough
  • Clears mucus effectively
  • Supports easy breathing
  • Reduces chest congestion
  • Improves airway clearance
Key Indications
  • Productive cough in children
  • Bronchospasm
  • Chest congestion
  • Thick sputum associated respiratory conditions
Administration
To be administered orally as directed by the physician.
Recommended Usage
Dosage should be individualized according to age and clinical condition under medical supervision.
Dosage Form
Paediatric Syrup
AGIREST-L Syrup
Levosalbutamol 1 mg + Ambroxol HCl 30 mg + Guaiphenesin 50 mg
Paediatric Respiratory Care / Productive Cough Management
Paediatric Respiratory Care / Productive Cough Management
Levosalbutamol opens airways, Ambroxol breaks thick mucus, and Guaiphenesin enhances mucus expulsion.
  • Relieves productive cough
  • Clears mucus effectively
  • Supports easy breathing
  • Reduces chest congestion
  • Improves airway clearance
  • Productive cough in children
  • Bronchospasm
  • Chest congestion
  • Thick sputum associated respiratory conditions
To be administered orally as directed by the physician.
Dosage should be individualized according to age and clinical condition under medical supervision.

Explore Similar Products

Therapeutic Segments
0 +
Years of Operations
0 +
Key Brands
0 +
Quality Assurance
0 %

Request a Free Quote

Quick, customized pharma–nutra quotations.